LiveActive security incident?Get immediate response
CVE Record

CVE-2017-12716: Abbott Laboratories Accent and Anthem pacemakers manufactured prior to Aug 28, 2017 transmit unencrypted pa...

Abbott Laboratories Accent and Anthem pacemakers manufactured prior to Aug 28, 2017 transmit unencrypted patient information via RF communications to programmers and home monitoring units. Additionally, the Accent and Anthem pacemakers store the optional patient information without encryption. CVSS v3 base score: 3.1, CVSS vector string: AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N. Abbott has developed a firmware update to help mitigate the identified vulnerabilities.

UnknownCVSS not scoredNot KEV-listedUpdated
Glexia's TakeAutomated analysis

Security readout for executives and security teams

Some Abbott Accent and Anthem pacemakers made before August 28, 2017 could expose limited patient information because RF communications and optional stored patient data were not encrypted. The cited CVSS score is low, but healthcare organizations should treat it as a privacy and medical-device inventory issue. Exposure is likely limited to healthcare environments or patients using affected Abbott Accent or Anthem pacemakers manufactured before August 28, 2017. Organizations without these models, or with devices outside that manufacturing window, are not indicated as affected by the provided sources. Handle through medical-device risk management, not emergency incident response. Prioritize inventory confirmation, vendor-supported firmware planning, and patient privacy documentation for affected devices. Escalate if local inventory shows many unupdated devices. Mitigation focus: Identify affected Abbott Accent and Anthem pacemakers by model and manufacture date.; Coordinate with Abbott or clinical engineering on the available firmware update.; Follow the ICS-CERT and vendor advisory guidance for clinical deployment decisions..

Prepared

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · low confidence lookup

CWE-311: Exact CWE lookup

Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2017-12716 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Unknown
CVSS
Not scored
Known Exploited
No
Published
Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors
0Timeline events
0ADP providers
2Source links

CVSS and timeline data

No CVSS vectors or timeline events were available in the normalized CVE source material.

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
Abbott LaboratoriesAccent and AnthemAll versions of pacemakers manufactured prior to August 28, 2017Listed
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.

CWE-311 · source CWE mapping

Missing Encryption of Sensitive Data

Missing Encryption of Sensitive Data represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.